Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (31-40 of 936) with videos related to

Pageof 94
Sort By:
Neuro-Oncology|March 25, 2011
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?Michael Weller, Wolfgang Wick
Chinese Clinical Oncology|June 27, 2015
Brain metastasis research: a late awakeningMatthias Preusser, Michael Weller
ESMO Open|May 16, 2020
How we treat patients with brain tumour during the COVID-19 pandemicMichael Weller, Matthias Preusser
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Adjuvant therapyWolfgang Wick, Michael Weller
Brain Research. Molecular Brain Research|October 24, 2002
The role of caspases 9 and 9-short (9S) in death ligand- and drug-induced apoptosis in human astrocytoma cellsRobert Waltereit, Michael Weller
Neuro-Oncology|May 12, 2011
Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)Wolfgang Wick, Michael Weller
Neuro-Oncology|October 25, 2014
Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategiesPatrick Roth, Michael Weller
Current Opinion in Neurology|November 12, 2020
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Michael Weller, Guido Reifenberger
Current Opinion in Neurology|October 9, 2012
Prime time for molecular marker diagnostics in neuro-oncologyMichael Weller, Roger Stupp
Oncology Letters|June 18, 2016
Boswellic acid activity against glioblastoma stem-like cellsHannah Schneider, Michael Weller
Pageof 94

Showing results (31-40 of 936) with videos related to

Sort By:
Pageof 94
Neuro-Oncology|March 25, 2011
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?Michael Weller, Wolfgang Wick
Chinese Clinical Oncology|June 27, 2015
Brain metastasis research: a late awakeningMatthias Preusser, Michael Weller
ESMO Open|May 16, 2020
How we treat patients with brain tumour during the COVID-19 pandemicMichael Weller, Matthias Preusser
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Adjuvant therapyWolfgang Wick, Michael Weller
Brain Research. Molecular Brain Research|October 24, 2002
The role of caspases 9 and 9-short (9S) in death ligand- and drug-induced apoptosis in human astrocytoma cellsRobert Waltereit, Michael Weller
Neuro-Oncology|May 12, 2011
Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)Wolfgang Wick, Michael Weller
Neuro-Oncology|October 25, 2014
Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategiesPatrick Roth, Michael Weller
Current Opinion in Neurology|November 12, 2020
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Michael Weller, Guido Reifenberger
Current Opinion in Neurology|October 9, 2012
Prime time for molecular marker diagnostics in neuro-oncologyMichael Weller, Roger Stupp
Oncology Letters|June 18, 2016
Boswellic acid activity against glioblastoma stem-like cellsHannah Schneider, Michael Weller
Pageof 94